Financial reports
10-K
2013 FY
Annual report
28 Feb 14
10-Q
2013 Q3
Quarterly report
6 Nov 13
10-Q
2013 Q2
Quarterly report
2 Aug 13
ARS
2012 FY
Annual report to shareholders
9 May 13
10-Q
2013 Q1
Quarterly report
3 May 13
10-K
2012 FY
Annual report
8 Mar 13
10-Q
2012 Q3
Quarterly report
6 Nov 12
10-Q
2012 Q2
Quarterly report
3 Aug 12
10-Q
2012 Q1
Quarterly report
4 May 12
10-K
2011 FY
Annual report
13 Mar 12
Current reports
8-K
Termination of a Material Definitive Agreement
19 Mar 14
8-K
Departure of Directors or Certain Officers
28 Feb 14
8-K
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013
28 Feb 14
8-K
Tender and Support Agreement
11 Feb 14
8-K
Entry into a Material Definitive Agreement
30 Jan 14
8-K
Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013
13 Jan 14
8-K
Improving the lives of hospitalized patients
16 Dec 13
8-K
Departure of Directors or Certain Officers
26 Nov 13
8-K
Other Events
15 Nov 13
8-K
Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
5 Nov 13
Registration and prospectus
15-12B
Securities registration termination
1 Apr 14
25-NSE
Exchange delisting
19 Mar 14
POS AM
Prospectus update (post-effective amendment)
19 Mar 14
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Mar 14
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Mar 14
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Mar 14
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Mar 14
SC 14D9/A
Tender offer solicitation (amended)
19 Mar 14
SC TO-T/A
Third party tender offer statement (amended)
19 Mar 14
SC 14D9/A
Tender offer solicitation (amended)
11 Mar 14
Proxies
DEF 14A
Definitive proxy
26 Apr 13
DEF 14A
Definitive proxy
26 Apr 12
DEF 14A
Definitive proxy
27 Apr 11
DEF 14A
Definitive proxy
29 Apr 10
DEF 14A
Definitive proxy
29 Apr 09
DEF 14A
Definitive proxy
28 Apr 08
DEF 14A
Definitive proxy
30 Apr 07
Other
CT ORDER
Confidential treatment order
14 Apr 14
EFFECT
Notice of effectiveness
19 Mar 14
CT ORDER
Confidential treatment order
3 Dec 13
CT ORDER
Confidential treatment order
17 Jun 13
CT ORDER
Confidential treatment order
6 Jun 13
CT ORDER
Confidential treatment order
6 Jun 13
EFFECT
Notice of effectiveness
5 May 11
CORRESP
Correspondence with SEC
3 May 11
CORRESP
Correspondence with SEC
12 Apr 11
UPLOAD
Letter from SEC
7 Apr 11
Ownership
SC 13D/A
Cadence Pharmaceuticals Inc
24 Mar 14
SC 13D/A
Cadence Pharmaceuticals Inc
20 Mar 14
SC 13D/A
Cadence Pharmaceuticals Inc
20 Mar 14
SC 13D
Cadence Pharmaceuticals Inc
13 Mar 14
SC 13G/A
Cadence Pharmaceuticals Inc
10 Mar 14
SC 13G/A
Cadence Pharmaceuticals Inc
14 Feb 14
SC 13G/A
Cadence Pharmaceuticals Inc
13 Feb 14
SC 13G/A
Cadence Pharmaceuticals Inc
13 Feb 14
SC 13G/A
Cadence Pharmaceuticals Inc
13 Feb 14
SC 13G/A
Cadence Pharmaceuticals Inc
5 Feb 14